While the $80 billion revenue…
While the $80 billion revenue target AstraZeneca set for 2030 [...]
While the $80 billion revenue target AstraZeneca set for 2030 [...]
Ionis Pharmaceuticals’ launch of Tryngolza (olezarsen) is off to a [...]
Less than four months after rejecting Sentynl Therapeutics and Cyprium [...]
AbbVie has announced a deal with the White House to [...]
A study of more than 5,000 pages of agency documents [...]
Already on track to achieve blockbuster status in its third [...]
With $10 billion pledged to beef up its U.S. operations [...]
His discovery of the protein fragment GLP-1 was crucial in [...]
Sam Rodriques, the C.E.O. and co-founder of FutureHouse, discusses the [...]
RTI Health Solutions leaders explain how patient voices are reshaping [...]